However, drugs such as Wegovy and Zepbound come with a high price ... are responding to the dilemma by implementing a $20,000 cap on spending per employee. However others, including RWJBarnabas ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...

Popular diabetes and weight-loss drugs Ozempic, Rybelsus and Wegovy are among 15 drugs selected ... the Inflation Reduction Act’s $2,000 annual cap on out-of-pocket drug costs for those on ...

The selected drug list for the second cycle of negotiations is: Novo Nordisk's (NYSE:NVO) diabetes and weight loss drugs, Ozempic, Rybelsus, and Wegovy ... an out-of-pocket cap of $2,000 for ...

Medicare beneficiaries are projected to save $7.2 billion annually from the $2,000 out-of-pocket cap starting in 2025. Get Wall Street's Hottest Chart Every Morning On Friday, the U.S. Department ...